An early small clinical trial in the treatment of advanced melanoma is using an attack on the melanoma cells using their own genetic characteristics. 9 of 16 patients with advanced melanoma responded to a drug known as
The broader picture here is that scientists now can examine the genetic make-up of certain cancers and develop therapies to combat the cancer based on the cancers genetic design.
BRAF is essential to the growth of certain cancers. So developing drugs to inhibit or shut off this gene will lead to less tumor growth.
How long will the effects of these new genetic drugs last?
No comments:
Post a Comment